Endometriosis in New Zealand: closing the gap between current practice and optimal care
This presentation will critically examine the current state of endometriosis diagnosis and management in New Zealand, highlighting gaps between clinical practice and best-evidence care. It will present findings from national public service surveys conducted in 2020 and 2026, illustrating progress, persistent inequities, and system constraints. New Zealand’s approach will be benchmarked against Australia following implementation of the National Endometriosis Action Plan, with a focus on actionable lessons to improve outcomes for patients.
Navigation guide – the new RANZCOG Living Evidence Guideline
Cindy will be presenting the new recommendations from the 2025 Endometriosis Guideline developed by RANZCOG. She will highlight new developments in diagnosis and management.
Cindy is the Postgraduate Professor of Obstetrics and Gynaecology at the University of Auckland and works as an obstetrician and gynaecologist, and fertility specialist at National Women’s Health.
Cindy trained in New Zealand and in London. Cindy has led the Cochrane Gynaecology and Fertility group since 1996. She is also a clinical trialist. She has also been the Co-Chair of the Cochrane Board 2014 to 2018.
Cindy is also the Dean of Research and Policy for the Royal Australian and New Zealand College of Obstetrics and Gynaecology. In 2024 Cindy and her team were awarded the Beavan Medal.
Diagnosis – Sounding the depths: Endometriosis ultrasound scanning
This
presentation will reframe endometriosis diagnosis beyond surgery as the default gold
standard, showing how contemporary ultrasound can deliver a confident diagnosis
that often allows patients to avoid diagnostic surgery. Practical scanning
strategies, including evolving techniques for superficial disease, will be
discussed with a focus on real-world clinical impact.
His clinical practice sits at the intersection of endometriosis and fertility, with high-quality ultrasound integrated into every consultation.
Calming the storm – Hormone suppression in 2026 and beyond
Hormonal management is a mainstay treatment for endometriosis. This session will unpack the different hormonal options available in New Zealand and internationally with a focus on tailoring choices for individual patients.
Charting new waters – beyond the horizon: Biomarkers, Sclerotherapy, AI
This presentation explores emerging frontiers that could transform diagnosis and treatment of endometriosis. We highlight the promise of novel biomarkers, innovative sclerotherapy techniques, and the expanding role of artificial intelligence in improving precision care for endometriosis. It invites clinicians and researchers to look ahead to a future where earlier detection and personalised therapies are within reach.
Jessica is a New Zealand trained Obstetrician and Gynaecologist. She obtained her Fellowship of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (FRANZCOG) in 2021, then completed two further years of advanced training in laparoscopic surgery in Auckland.
Jessica practices as a consultant Obstetrician and Gynaecologist at Te Toka Tumai Auckland as part of the minimal access surgery team. Her clinical interests are in the diagnosis and treatment of endometriosis, abnormal uterine bleeding and fibroids.